Lan-ping Ma

发表

CCLab--a multi-objective genetic algorithm based combinatorial library design software and an application for histone deacetylase inhibitor design.

Mengzhu Xue, B. Xiong, Jing-kang Shen, 2012, Bioorganic & medicinal chemistry letters.

Palladium‐Catalyzed Route to Three‐Component, One‐Pot Sequential Synthesis of Functionalized Cyclazines: 2,2a1,4‐Triazacyclopenta[cd]indenes

Jing-kang Shen, Lan-ping Ma, T. Meng, 2013 .

Discovery of novel PTP1B inhibitors with antihyperglycemic activity

Jia Li, Jing-kang Shen, Q. Chai, 2010, Acta Pharmacologica Sinica.

Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody–Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function

Jing-kang Shen, Yun Xing, Xin Wang, 2020, Molecular Cancer Therapeutics.

Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers

Z. Miao, B. Xiong, Jing-kang Shen, 2021, Investigational New Drugs.

MCL-1 Degradation Mediated by JNK Activation via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189

Yi Chen, Z. Miao, Jian Ding, 2014, Molecular Cancer Therapeutics.

3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists.

Wei-Chang Fu, H. Sarau, J. Foley, 2007, Bioorganic & medicinal chemistry letters.

Facile synthesis of new functionalized 3,4-dihydro-2H-pyrroles using 2-isocyanoacetates

Jing-kang Shen, Lin Chen, Xin Wang, 2020 .

Ga(OTf)3-promoted synthesis of functionalized 2-carbonyl-imidazo[1,2-a]pyridines derived from ethyl α-benzotriazolyl-α-morpholinoacetate

Jing-kang Shen, Xin Wang, Lan-ping Ma, 2015 .

Simple and Efficient Copper(I)-Catalyzed Access to Three Versatile Aminocoumarin-Based Scaffolds using Isocyanoacetate

Jing-kang Shen, Xin Wang, D. Hu, 2011 .

Discovery of pyrazole as C-terminus of selective BACE1 inhibitors.

Yechun Xu, Li Li, Jian Li, 2013, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.

Wei Wang, Jingkang Shen, Xin Wang, 2009, Bioorganic & medicinal chemistry.

Illudalic acid as a potential LAR inhibitor: synthesis, SAR, and preliminary studies on the mechanism of action.

B. Xiong, Jing-kang Shen, Xin Wang, 2008, Bioorganic & medicinal chemistry.

Soluble polymer-supported synthesis of 5-arylidene thiazolidinones and pyrimidinones using a novel traceless linker strategy.

Wei Zhang, Jing-kang Shen, Xin Wang, 2008, Journal of combinatorial chemistry.

Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer

Jing-kang Shen, Xin Wang, Lan-ping Ma, 2016, Oncotarget.

Synthesis and LAR inhibition of 7-alkoxy analogues of illudalic acid.

B. Xiong, Jing-kang Shen, Xin Wang, 2010, Yao xue xue bao = Acta pharmaceutica Sinica.

Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma

Hui Zhao, Jing-kang Shen, Lan-ping Ma, 2017, Oncotarget.

MT119, a new planar‐structured compound, targets the colchicine site of tubulin arresting mitosis and inhibiting tumor cell proliferation

Yi Chen, Z. Miao, Jian Ding, 2011, International journal of cancer.

AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage

K. Yu, Lan-ping Ma, T. Meng, 2023, Acta Pharmacologica Sinica.